Intelligent Bio Solutions stock rises after announcing a manufacturing partnership targeting over 40% cost savings, major ...

Adicet Bio ( ($ACET) ) has issued an update. On December 19, 2025, Adicet Bio’s shareholders approved, and its board subsequently set, a 1-for-16 ...

Investing.com -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) stock fell 21.3% in after-hours trading Wednesday following the company’s announcement of a $10 million private placement with two ...

Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...

Palisade Bio said the findings demonstrated PALI-2108 exhibited efficient ex-vivo conversion into its active PDE4 inhibitor form in stool samples from both normal healthy volunteers and patients with ...

Climb Bio ( ($CLYM) ) just unveiled an announcement. On December 31, 2025, Climb Bio, Inc. filed a complaint in Delaware Superior Court against ...

Nuvation Bio stock has been on a roll since late October, as the shares have roughly tripled since then. The main driver of this rally is the potentially transformative acquisition of AnHeart ...

If a little bird told you to think about buying Bluebird Bio (NASDAQ: BLUE) stock recently, there's a lot of information you'll need to evaluate. Between the new product that this small biotech has ...

Nuvation Bio enrolled the first patient in a late-stage study of Ibtrozi. The bigger story, though, was a Wall Street analyst's initiation of coverage on the stock. Shares of Nuvation Bio (NYSE: NUVB) ...

I rate Bio-Rad (BIO) with a buy rating. I start by mentioning that the low growth perspective is the negative aspect. For 2025, the company expects a 0.25% growth rate for its revenues, which might ...

Bluebird Bio has launched three gene-editing therapies. These treatments are expensive and complex to administer, and they face stiff competition. Though Bluebird Bio is an innovative biotech, the ...